3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Stomach Neoplasms
132
Pancreatic Neoplasms
36
Esophageal Neoplasms
19
Biliary Tract Neoplasms
18
Colorectal Neoplasms
17
Esophageal Squamous Cell Carcinoma
12
Neoplasm Metastasis
10
Cholangiocarcinoma
7
Carcinoma, Non-Small-Cell Lung
7
Gastrointestinal Neoplasms
6
Nasopharyngeal Carcinoma
5
Colonic Neoplasms
5
Adenocarcinoma
5
Neoplasms
4
Head and Neck Neoplasms
4
Advanced Pancreatic Cancer
4
Advanced Gastric Cancer
4
Recurrence
3
Rectal Neoplasms
3
Gastric Adenocarcinoma
3
Advanced Solid Tumors
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
NSCLC
2
Locally Advanced Pancreatic Cancer
2
Locally Advanced Gastric Cancer
2
Gastric Cancer Peritoneal Metastases
2
Gallbladder Neoplasms
2
Carcinoma, Transitional Cell
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Interventions
Radiotherapy
29
Cisplatin
12
Amifostine
11
Radiotherapy, Intensity-Modulated
7
Paclitaxel
7
Carboplatin
7
Etoposide
5
Radiosurgery
4
Donepezil
4
Brachytherapy
4
Bevacizumab
4
sargramostim
3
Surgical Procedures, Operative
3
Mental Status and Dementia Tests
3
Filgrastim
3
Diet Therapy
3
Blood Specimen Collection
3
Radiation Dose Hypofractionation
2
Radiation
2
Proton Therapy
2
Magnetic Resonance Spectroscopy
2
Low-Level Light Therapy
2
Lithium
2
Hyperbaric Oxygenation
2
Heavy Ion Radiotherapy
2
Fluorouracil
2
Fibroblast Growth Factor 7
2
Dexamethasone
2
Chemotherapy, Adjuvant
2
Androgen Antagonists
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Radiation Injuries
×
S 1 (combination)
×
Clear all
NCT04274270
2020-03-19
SBRTLCES
Peking University Third Hospital
Phase NA
Unknown
60 enrolled